Treatment of MCF-7 and MDA-MB-231 human breast cancer cell lines with erythropoietin, doxorubicin and their combination
The cancer chemotherapies are formulated to target the rapidly proliferating cancer cells more efficiently than those normal cells of low proliferating rate. In cancer therapies erythropoietin (EPO) is often used in combination with chemotherapeutic drugs to treat the cancer-associated anemia. In th...
Saved in:
| Main Author: | Radwan, Esam M. |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2015
|
| Online Access: | http://ethesis.upm.edu.my/id/eprint/12276/1/FPV%202015%203%20-%20T.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of MCF-7 and MDA-MB-231 human breast cancer cell lines with erythropoietin, doxorubicin and their combination
by: Radwan, Esam M.
Published: (2015) -
Effect of recombinant human erythropoietin and doxorubicin in combination on the proliferation of MCF-7 and MDA-mb231 breast cancer cells
by: Radwan, Esam M., et al.
Published: (2016) -
In vitro treatment of MCF-7 and MDA-MB-231 breast cancer cell lines with doxorubicin and vincristine sulphate calcium carbonate nanoparticles
by: Mengyi, Xue
Published: (2019) -
In vitro treatment of MCF-7 and MDA-MB-231 breast cancer cell lines with doxorubicin and vincristine sulphate calcium carbonate nanoparticles
by: Mengyi, Xue
Published: (2019) -
In vitro treatment of MCF-7 and MDA-MB-231 breast cancer cell lines with doxorubicin and vincristine sulphate calcium carbonate nanoparticles /
by: Mengyi, Xue,
